oarsi_white_paper_oa_serious_disease_121416_1 | Virpax Pharmaceuticals

oarsi_white_paper_oa_serious_disease_121416_1

oarsi_white_paper_oa_serious_disease_121416_1

admin2021-10-25T16:14:46-04:00October 25th, 2021|

oarsi_white_paper_oa_serious_disease_121416_1

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma